NCT01014598View on ClinicalTrials.gov

Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

December 4, 2007

Primary Completion Date

October 23, 2013

Study Completion Date

May 1, 2017

Conditions
Metastatic Malignant Neoplasm in the LungStage IIIB Non-Small Cell Lung CancerStage IV Adult Soft Tissue SarcomaStage IV Non-Small Cell Lung Cancer
Interventions
DRUG

Cisplatin

Given intra-arterially via isolated lung suffusion

OTHER

Pharmacological Study

Correlative studies

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT01014598 - Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis | Biotech Hunter | Biotech Hunter